PEAK1 and neoplasm: In the present study, the blockade of PEAK1 expression inhibited cell growth, invasion and migration in vitro, and inhibited tumor growth and lung metastasis in vivo, suggesting that PEAK1 is the target gene for breast cancer gene therapy.